Tarsus Pharmaceuticals, Inc. (TARS) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $451.36M | +146.7% |
| 2024 | $182.95M | +948.6% |
| 2023 | $17.45M | -32.4% |
| 2022 | $25.82M | -54.7% |
| 2021 | $57.03M | — |
| 2020 | $0 | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $451.36M | +146.7% |
| 2024 | $182.95M | +948.6% |
| 2023 | $17.45M | -32.4% |
| 2022 | $25.82M | -54.7% |
| 2021 | $57.03M | — |
| 2020 | $0 | — |